A global leader in neurovascular innovation, MicroVention is now Terumo Neuro. This name change signifies a new chapter in the companys evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.
We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, ...
A global leader in neurovascular innovation, MicroVention is now Terumo Neuro. This name change signifies a new chapter in the companys evolution while maintaining its unwavering commitment to the creation and commercialization of groundbreaking innovations in neurovascular care.
We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica.
-
Number of Employees:
250-1000
-
Annual Revenue:
$250-500 Million